SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Targacept (TRGT)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kenhott who wrote (10)10/2/2006 11:00:59 PM
From: keokalani'nui of 40
 
2005--right. I think they had some drug failures in the meantime pre-IPO, possibly even the lead program(s).

It would be nice if they get the two other cpds into the clinic before AZN drops the bomb or the balloons. If they do one won't lose it all on azn's decision, just half of it.

That cognition data looked good, though, to me. The safety thing, a drug like this, is always going to be a question.

The one thing azn's rework does say loud and clear is that management's drug development expertise may lack, mmmm, rigor. The birthing and staffing of trgt doesn't do much for my confidence either--your point is well taken. Today, all I can say about the management issue anywhere is.....NBIX.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News